REGULATED INFORMATION GHENT, Belgium, 28 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] ...
Investor briefing to be webcast from Chicago on Monday, June 4, 2018 at 6:15PM ...
Clinically meaningful benefit observed in NEWTON 2 primary endpoint in pre-specified WFNS 3 or ...
